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Introduction  
 
Down syndrome is frequently associated with congenital anomalies, particularly of the 
cardiac system. People with Down syndrome are at higher risk than others for a range 
of conditions, including cardiac, respiratory, immunological, endocrine, and gastro-
intestinal conditions. This physical phenotype puts people with Down syndrome at risk 
of dying at a younger age than the general population. In the mid-20th Century, 
average survival of a child with Down syndrome was to about 10 years of age, but this 
is thought to have increased markedly over subsequent decades, in particular due to 
access to treatments for congenital heart anomalies and improved surgical techniques 
and post-operative care (Hijii et al., 1997).   
 
Changes in public attitudes have impacted on access to surgery and interventional 
care. As recently as the 1980s and 1990s there were reports of children with Down 
syndrome being offered conservative management rather than surgical interventions 
for congenital heart anomalies (Bull et al., 1985; Kmietowicz, 2001); e.g. outcomes 
were presented for 67 children with Down syndrome and atrioventricular canal defects 
who were not given surgery (Bull et al., 1985). Others rejected this view and advocated 
for an equal provision of surgery (Wilson et al., 1985; Menahem & Mee, 1985). The 
British Medical Association Handbook of Medical Ethics (1984) at this time also 
endorsed the view that in certain circumstances severely malformed children could be 
allowed to die. A pivotal case in testing public attitudes was that of R v Arthur. In 1981 
Dr. Leonard Arthur was acquitted of the murder of a baby with Down syndrome. The 
baby was rejected at birth by its parents and Dr. Arthur made a note “Parents do not 
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wish it to survive. Nursing care only”, food was withheld and opioid pain relief (which 
has a side effect of respiratory suppression) was prescribed four hourly. The baby died 
after 69 hours with the cause of death recorded as bronchopneumonia. Clearly these 
practices are no longer acceptable, and technological and medical advancements 
related to treating congenital heart anomalies for people Down syndrome are likely to 
have influenced improved survival rates and older age of death (Coppus et al., 2006; 
Glasson et al., 2016).   
 
However this evidence needs further investigation.  There is also a need for 
quantification of the extent of improved survival rates, and identification of causes of 
death and the factors influencing death.  
 
We have been unable to identify any existing systematic review and synthesis of 
evidence on early deaths and specific causes of death for people with Down syndrome 
which could identify health inequality trends amongst people with Down syndrome, 
important for healthcare decision making and to inform strategies for reducing 
inequalities. The aim of this study was therefore to systematically review the evidence 
on early deaths amongst people with Down syndrome, determinants of early death, 
and the main causes of death.  
 
Method 
This review was conducted alongside a systematic review into early death and causes 
of death of people with intellectual disabilities. A clear search strategy and protocol 
was devised. The review protocol was registered with the International Prospective 
Register of Systematic Reviews (Prospero) (registration number: CRD42015020161).  
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CINAHL, MEDLINE, PsychINFO, Web of Science, and EMBASE online databases 
were searched for key words relating to intellectual disabilities and Down syndrome. 
These databases were also searched for key words relating to mortality, age of death 
and life expectancy (appendix 1). The search was completed on 20/10/16. The search 
results were filtered for English language and human. The following strict inclusion 
and exclusion criteria were applied when selecting the relevant studies.  
Inclusion criteria 
 Studies that report deaths or mortality rates of people with Down syndrome   
 A minimum of 50% of participants have intellectual disabilities, if not reported 
separately 
 Peer reviewed  
 Primary research 
 All ages 
 All years 
 All study designs. 
Exclusion criteria   
 Full paper not accessible in English  
 Proportion of participants with intellectual disabilities unclear, or <50% of 
sample if not reported separately 
 Studies that do not clearly report mortality outcomes separately for people with 
Down syndrome  
 >50% of sample reside in institutional settings 
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 Studies reporting mortality rates/cause and age of death following 
relocation/resettlement   
 Studies reporting post-operative and post-treatment deaths  
 Case studies or case series for total sample of <20 participants  
 Studies exclusively focussed on specialised populations such as those living in 
a specific type of residency only, or accessing a specific type of service only.    
Study selection and data extraction  
The titles that were identified from the five online databases were entered into the 
Endnote reference manager software. Duplicates were removed. Titles and abstracts 
were then assessed for inclusion. Five percent of these studies were then checked by 
a second reviewer. Disagreements or discrepancies were resolved with a third 
reviewer, until consistency was achieved between reviewers. Full papers were then 
assessed for inclusion by two reviewers. 
Authors were contacted if the full paper could not be retrieved and if the reviewers 
were not clear about specific details of the study, to verify if the study met the inclusion 
criteria. Six authors were contacted for these purposes. 
The reference lists of included studies were also searched in detail for any additional 
papers of relevance. Data were then systematically extracted from the included 
studies. This related to study characteristics, size, demographics, 
inclusions/exclusions, context, location, design, data source, comparator groups, 
analytical method, outcomes, findings and risk of bias. Information was tabulated in a 
database.  
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Meta-analysis and narrative analysis were two possible methods of synthesising this 
data. It has been argued that meta-analysis may be a more objective and less biased 
approach than narrative analysis (Cooper & Rosenthal, 1980). Different methods were 
used to measure life expectancy, age of death, and causes of death of the participants 
in these studies. Therefore it was not possible to use a meta-analysis in order to 
numerically synthesise the results of different studies (Glass et al.,1976), and narrative 
analysis was used. (Popay et al., 2006).  
The Critical Appraisal Skills Programme CASP (2013) guidelines were used to 
appraise the quality and rigour of the studies. This checklist scored the studies out of 
a possible 14 points based on their validity, reliability and generalisability. The CASP 
scores were checked with a 2nd researcher and any discrepancies were resolved with 
a 3rd reviewer. This approach helped to reduce any prospective bias associated with 
narrative analysis.  
Results 
Figure 1 illustrates the steps take in this review in order to identify relevant studies. A 
total of 24,702 references were retrieved from searching five databases. Two 
additional articles were identified from a reference in a relevant paper. N=19,111 of 
these articles were relevant after removing duplicates. These studies dated from 1796-
2016. 
N=17,010 were excluded, as these titles were not relevant to the purpose of population 
of the study. N=2101 abstracts were checked.  N=322 of the abstracts were 
considered potentially relevant and these papers were read in depth.  All reviewers 
agreed on the eligibility of the included studies. N=288 of the articles read in full did 
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not meet the inclusion criteria, whilst N=34 did. The findings from these studies were 
synthesised (tables 1-3).  
- Insert tables 1-3 about here -  
Country of studies  
N=10/34 of the studies that were included in the narrative synthesis were undertaken 
within the USA (Scholl,1982; Eyman et al., 1991; Strauss & Eyman, 1996; Singer & 
Straus, 1997; Friedman, 2001; Yang et al. 2002; Day et al., 2005; Rasmussen et al., 
2006; Shin et al., 2007; Goldman et al., 2011). Six were conducted in Australia 
(Mulcahy, 1979; Malone, 1988; Leonard et al., 2000; Glasson et al., 2002; Bittles et 
al.,2007; Glasson et al.,2016); four were from the UK region (McGrother & 
Marshall,1990; Brookes & Alberman,1996; Bell et al., 2003; Kucik et al., 2013); and 
four were undertaken in Canada (Gallagher & Lowry, 1975; Baird & Sadovnick ,1987; 
Baird & Sadovnick, 1988; Baird & Sadovnick, 1990). Two studies were undertaken in 
each of Sweden (Frid et al., 2004; Englund et al., 2012) and Denmark (Mikkelsen et 
al., 1990, Zhu et al., 2013). The remaining studies were from New Zealand (Bell et al., 
1989); Italy (Mastroiacovo et al., 1992); Ireland (Hayes et al., 1997); South America, 
specifically Argentina, Brazil, Chile, Paraguay, Uruguay (Castilla et al., 1998), Japan 
(Masaki et al., 1981), and Israel (Sadetzki et al.,1999). Hence all studies are from high 
income countries with the exception of one which included two upper middle income 
countries (Brazil and Paraguay). 
Studies on early death   
N=32/34 studies included in this review reported life expectancy, mortality rates or age 
of death of people with Down syndrome. A diverse range of methods were used to 
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assess age of death. This information is summarised on tables 1 and 2. These 
included measures of actual/predicted survival and median age of death.  Some 
studied crude or standardised mortality rates. Studies also reported factors associated 
with early deaths, life expectancy and mortality rates. The majority of studies (N=17) 
only reported on mortality patterns and age of death in infants and childhood (<age 18 
years) (see table 2). N=15 studies assessed age of death, life expectancy and 
mortality patterns of individuals with Down syndrome of all ages (table 1).  
The diverse methods used to analyse deaths across these studies complicated the 
synthesis of the findings.   
Mortality rate, life expectancy and age of death comparisons with the general 
population  
Life expectancy and age of death was lower and mortality rates were higher for people 
with Down syndrome. For example Baird & Sadovnick (1988) identified that the life 
expectancy from birth of their cohort of N=1,610 individuals with Down syndrome was 
28 years lower than the general population. Friedman (2001) reported that the median 
age of death within their sample of N=33,836 people with Down syndrome was 27 
years younger than the general population. Glasson et al., (2002) reported that in their 
sample of N=1,332 individuals with Down Syndrome that the median age of survival 
was 17-23 years lower than for the general population. Day et al. (2005) reported that 
standardised mortality rates in their USA study of individuals with Down syndrome 
were 5.5 times higher than the general population, and Zhu et al., (2013) reported that 
the adjusted hazard ratio for mortality was 9.0 times higher in their Danish cohort of 
individuals with Down syndrome compared to the general population.  
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Several studies reported that infant mortality rates were significantly higher and 
survival rates were lower in Down syndrome compared to the general infant population 
(Mastroiacovo et al., 1992; Hayes et al., 1997; Sadetzki et al., 1999; Bell et al., 2003; 
Frid et al., 2004; Studies undertaken in the last decade reported that one year mortality 
rates were 6 to 8 times greater than that of the general population (Shin et al., 2007; 
Goldman et al., 2011).  Earlier studies reported that one year Down Syndrome 
mortality rates were up to 24 time higher than that of the general population (Sadetzki 
et al., 1999). This figures show some improvement in survival rates over time. 
Temporal trends in mortality patterns  
Strikingly, studies consistently identified that infant mortality rates reduced, and life 
expectancy improved over time for children and adults with Down syndrome, 
particularly those with congenital heart anomalies (see Table 2). For example, Malone 
(1988) reported significant improvements in 5 year survival rates for their Australian 
cohort of children with Down syndrome and congenital heart anomalies from 1966-
1976; Hayes et al., (1997) reported that that in Ireland, 1 year and 5 year survival rates 
were higher for children with Down syndrome who were born in 1985-1989, compared 
to children who were born in 1980-1984.  Frid et al., (2004) and Shin et al., (2007) 
reported that 1 year mortality rates decreased by 12% and 41% respectively for infants 
with Down syndrome born in the 1970s compared to those born in the 1990s.    
These improvements were also observed in studies that comprised individuals of all 
ages (see table 1). For example Bittles et al., (2007) reported a 9% reduction in age 
specific mortality trends for a cohort of individuals with Down syndrome born in 2000-
2004, compared to earlier cohort born in 1980-1984.  Englund et al., (1997) reported 
a very large increase in median age from 3.6 years to 56.8 years from 1969-2003. 
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The greatest temporal changes were reported for individuals with Down syndrome who 
also had congenital heart anomalies. For example, Kucik et al., (2013) reported a great 
improvement in 1 year survival amongst a USA cohort of N=16,506 individuals with 
Down syndrome and congenital heart anomalies between 1983-2003 (see table 1). 
The influence of congenial heart anomalies on life expectancy and age of death was 
most apparent in earlier birth cohorts. For example Glasson et al., (2016) in comparing 
five year survival rates between birth cohorts within a Western Australian context 
identified that the earliest birth cohort, born in 1980-1985 had a 93% survival rate to 
age five for children with Down syndrome without congenital heart anomalies, and a 
72% survival rate to age five for children with Down syndrome with congenital heart 
anomalies. These differences were smaller for the later birth cohort, born in 2006-
2010, which had a 95% survival rate for children with Down syndrome without 
congenital heart anomalies, and a 92% survival rate for children with Down syndrome 
with congenital heart anomalies.  
Factors associated with mortality rates and early deaths 
Congenital heart anomalies: Consistently, mortality probabilities were reported to be 
higher and survival probabilities were lower for infants and children with congenital 
heart anomalies (Mulcahy et al., 1979; Masaki et al., 1981; Malone, 1988; Mikkelsen 
et al., 1990; Leonard et al., 2000; Rasmussen et al., 2006), and actual survival rates 
were lower and mortality rates were higher for children with Down syndrome and 
congenital heart anomalies (Mastroiacovo et al.,1992, Hayes et  al.,1997;  Castilla et 
al., 1998; Bell et al., 2003;  Shin et al., 2007).  This association also emerged in some 
of the studies comprising individuals of all ages (Baird & Sadovnick, 1987). Day et al., 
(2005) reported that age specific mortality rates were higher for their sample of people 
with Down syndrome and congenital heart anomalies compared to the general 
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population, significantly so for those aged <50years, but not significantly so for those 
aged >50years.   
Age: Several studies reported that mortality rates in Down syndrome were the highest 
in infancy and early childhood compared to older children and young adults (Gallagher 
& Lowry, 1975; Baird & Sadovnick,1988), particularly so in early infancy (Mulcahy, 
1979; Malone, 1988; Masaki et al., 1981). 
Ethnicity: Race and ethnicity also had an influence on mortality patterns and age of 
death in both infant and child/adult studies (see tables 1 and 2). White ethnicity 
appeared to be associated with lower mortality rates and improvements in life 
expectancy over time compared to other ethnic groups, whilst black ethnicity was 
associated with lower survival probability (Rasmussen et al., 2006; Kucik et al.,2013) 
and high mortality rates (Day et al., 2005; Shin et al., 2007). Leonard et al., (2000) 
identified how aboriginal ethnicity was associated with lower one year survival 
probability amongst their cohorts of Australian infants with Down syndrome, whilst 
Glasson et al., (2016) identified that aboriginal ethnicity was associated with lower 
survival rates among their sample of 1,378 adults with Down syndrome. In the USA 
Friedman (2001) and Yang et al., (2002) revealed that an increase in median age of 
death for individuals with Down syndrome over time was greatest amongst individuals 
from a white ethnic background.  
Other factors: Higher mortality rates were also associated with severe level of 
intellectual disabilities (Strauss & Eyman, 1996; Singer & Straus, 1997), and presence 
of medical conditions (Sadetzki et al., 1999).  Co-morbidities particularly feeding and 
mobility impairments appeared to reduce life expectancy (Eyman et al., 1991). Low 
birth weight increased mortality rates (Sadetzki et al., 1999) and reduced survival 
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length (Leonard et al., 2000; Rasmussen et al., 2006) amongst children with Down 
syndrome (Sadetzki et al., 1999), and low parental education also lowered survival 
rates of the Down syndrome offspring (Eyman et al., 1991). 
Three studies also identified that survival rates were lower for individuals with Down 
syndrome, compared to individuals with intellectual disabilities (no Down syndrome) 
(Baird & Sadovnick, 1987; Eyman et al., 1991; Singer & Strauss, 1997). 
Studies on causes of death 
Primary, underlying, and contributory causes of death  
It was difficult to determine consistent trends in primary, underlying and contributory 
causes of death and to ascertain whether the pattern of causes of death have changed 
over time, due to a variation in recording of causes of death across regions. Also, there 
was a relatively small number of studies that recorded primary and underlying causes 
of death, and only five studies recorded contributory causes. This limited capacity to 
identify whether and how cause of death may have changed over time by age group. 
However, some trends appeared (see table 3). 
Congenital heart anomalies: These were reported as leading primary or underlying 
cause of mortality in the majority of the studies, accounting for 30%-50% of causes of 
death in studies that were undertaken in USA, Denmark and Australia comprised of 
children and adults combined (Scholl et al., 1982; Baird & Sadovnick, 1990; Zhu et al., 
2013; Glasson et al., 2016). They were reported as accounting for a large proportion 
of deaths in studies that comprised infants and children with Down syndrome only in 
studies undertaken in Australia, Denmark, UK, Ireland and USA (Bell et al., 1989; 
Mikkelsen et al., 1990; McGrother & Marshall 1990; Hayes et al., 1997; Shin et al., 
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2007). These specific cause of death rates ranged from 33.9% in the most recent study 
undertaken by Shin et al., (2007) of infant deaths (born 1979-2003) to 65% in an older 
study conducted by McGrother and Marshall (1990) on a birth cohort of children born 
1976-1985. 
Incidences of congenital heart anomalies as a cause of mortality were reported to be 
lower amongst white ethnic groups in two USA studies (Yang et al., 2002; Rasmussen 
et al., 2006). 
Respiratory conditions: These were reported as another common underlying or 
primary cause of death in studies comprising adults and children accounting for 34% 
of a Canadian sample of deaths (Baird & Sadovnick, 1990), and 20% in a  more recent 
Danish study (Zhu et al., 2013). Bittles et al., (2007) reported that respiratory illness 
death rates were highest for individuals aged over 41 (39.6%) and lowest for 
individuals aged 0-18 years (33.1%) in their Australian sample of N=298 deaths of 
people with Down syndrome.  
Respiratory conditions were also reported as an underlying or primary cause of death 
in studies comprising infants and children. They accounted for 5% of 20 main causes 
of death in a UK sample of children born 1976-1985 (McGrother & Marshall, 1990). 
Hayes et al.,(1997) reported that respiratory illness in the absence of congenial heart 
anomalies accounted for 9.1% in an Irish sample of 63 deaths of infants that were born 
in 1980-1989.    
Pneumonia was identified as one of the main respiratory causes of death in Australian 
and Danish studies that comprised infants and children (Mulcahy, 1979; Mikkelsen et 
al., 1990), and USA, Australian and Swedish studies that comprised all ages (Scholl 
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et al., 1982; Day et al., 2005; Bittles et al., 2007; Englund et al., 2012; Glasson et al., 
2016).  
Other conditions: Circulatory disease accounted for 24% of 1,930 deaths at all ages 
in a Swedish study (Englund et al., 2012), 12.1% of 3,272 deaths at all ages in a 
Danish study (Zhu’s  et al. 2013), and 1.5% of 324 deaths up to age 32 in a US study  
(Baird &  Sadovnick, 1990).  Cardiac failure accounted for 33% of 55 infant deaths  in 
an Australian study (Mulcahy et al., 1979), and 18.8% of 16 reported causes of death 
up to age 5 in a UK study (Brookes & Alberman, 1996). These conditions were likely 
to be associated with congenital heart anomalies. Bittles et al., (2007) reported that 
cardiac/renal and respiratory failure deaths decreased with age in their Australian 
study. They reported that they accounted for 11.5% of causes of death in their sample 
of individuals aged 0-18 years and 9% of causes of death in their sample aged 40+ 
years.  
Other less common causes of death were leukaemia, which accounted for 2-13% of 
the main causes of death across nine studies undertaken in Australia, USA, UK, 
Denmark, Ireland and Sweden (Mulcahy, 1979; Scholl et al., 1982; Bell et al., 1989; 
Mikkelsen et al., 1990, Brookes & Alberman, 1996; Hayes et al., 1997; Englund et al., 
2012; Glasson et al., 2016). Whilst being a less common cause of death, leukaemia 
therefore clearly occurred more commonly than it does in the general population. 
Accidental deaths accounted for a small proportion (2-6%) of primary causes of death 
in studies undertaken in Australia, USA and Ireland (Mulcahy et al., 1979; Scholl et 
al., 1982; Baird & Sadovnick, 1990; Hayes et al., 1997; Bittles et al., 2007; Shin et al., 
2007). Down syndrome was reported as a primary or underlying cause of death in 
some studies undertaken in the USA (Baird & Sadovnick, 1990; Day et al., 2005; 
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Rasmussen et al., 2006; Shin et al., 2007), Sweden (Englund et al., 2012) and 
Australia Glasson et al., 2016). Perinatal conditions and complications were also 
reported as accounting for a small proportion of causes of death in two USA studies 
(Baird & Sadovnick, 1990; Shin et al., 2007) and one Danish study (Mikkelsen et al., 
1990) 
Contributory and intermediate causes of death were not recorded in most studies, so 
it was difficult to capture the sequence of events leading to mortality (see table 3). 
Down syndrome was recorded as a contributory cause of death in 93.8% by Brookes 
& Alberman (1996) and 44% by Shin et al., (2007). Down syndrome was reported to 
account for 51.5% of multiple cause of death in a USA study undertaken by Goldman 
et al., (2011). Other contributory cause of death included dementia in an Australian 
study undertaken by Bittles et al., (2007), respiratory disease/infections or 
complications in Australian, UK, Irish and US studies (Bell et al., 1989; Brookes & 
Alberman, 1996; Hayes et al.,1997; Goldman et al., 2011). Table 3 outlines other less 
common causes of death reported in individual studies. 
Comparisons of causes of death with the general population  
Congenital heart anomalies were substantially more common as a cause of death in 
Down syndrome than the general population (Scholl et al., 1982; Yang et al., 2002; 
Day et al., 2005). Englund et al. (2012) reported that Standardised Mortality Odds 
Ratios were 80 times higher in their sample of N=3,956 children with Down syndrome, 
compared to the general population.  
Pneumonia was also a lot more common cause of death amongst people with Down 
syndrome than in the general population. Day et al., (2005) reported Standardised 
Mortality Ratios of 140.4 for aspiration pneumonia as a cause of death amongst 
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individuals with Down syndrome compared with the general population, whilst Yang et 
al., (2002) identified aspiration pneumonia or influenza to be 7.6 times more common, 
with this difference increasing with age, and Englund et al., (2012) reported that 
respiratory illness (including pneumonia) was 5.6 times more common. 
Two USA studies identified dementia/Alzheimer disease to be more common causes 
of death amongst people with Down syndrome compared to the general population. 
Day et al., (2005) reported an SMR of 154.6, and Yang et al., (2002) reported a SMOR 
of 21.1 at age >40 years.  
Three studies undertaken within the USA and Sweden reported that rates of leukaemia 
deaths were higher for people with Down syndrome than the general population. 
Scholl et al., (1982) reported that proportional mortality ratios for leukaemia were 
significantly higher compared to the general population for children with Down 
syndrome aged 2-4 years and adults aged 20-34 years. Yang et al., (2002) and 
Englund et al. (2012) identified that SMORs for leukaemia were 1.6 and 1.7 times 
higher for people with Down syndrome compared to the general population in their 
respective studies. Yang et al., (2002) reported that SMORS were highest at age <10 
years.  
Less common causes of death amongst people with Down syndrome compared to the 
general population included ischaemic heart disease (Scholl et al., 1982; Yang et al., 
2002) and cancers such as digestive/genital/ breast and lung cancer (Scholl et al., 
1982; Day et al., 2005).  
Discussion 
Principal findings 
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People with Down syndrome have a life expectancy about 28 years lower than the 
general population; their life expectancy has increased over time, this is particularly 
true for infant mortality, and for those who additionally have congenital heart anomalies 
(more so for white than non-white ethnicity). Survival rates are lower in the first year 
of life, than in childhood or young adult life. Survival is poorer for those with congenital 
heart anomalies, non-white ethnicity, more severe intellectual disabilities, low birth 
weight, additional medical conditions, feeding and mobility problems, and for offspring 
of younger mothers and parents with lower educational levels. The pattern of cause of 
deaths differs from the general population, with cardiac and respiratory deaths most 
common and occurring substantially more so than in the general population. Solid 
tumours are less common causes of death than for the general population, but 
leukaemia, whilst not a common cause of death in people with Down syndrome is 
considerably more common than in the general population.  This is the first systematic 
review to synthesise these studies of death of people with Down syndrome across the 
life span.  
The increase in life expectancy and age of death was most apparent for individuals 
with congenital heart anomalies. This improvement is likely to be due to early 
diagnosis and better-quality health care intervention for individuals with congenital 
heart anomalies, in particular access to surgical intervention, and better surgical 
technique and post-operative care (Bernier et al., 2010). The ethnic differences in 
survival could possibly reflect a poorer access to surgery and/or poorer care, and if so 
would be an inequality that could be amenable to improvements in health care. Clearly 
this needs further investigation, and action if inequitable health care is found. Other 
cultural factors may also be important in accounting for average age of death or life 
expectancy of individuals from black or minority ethnic backgrounds not improving at 
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the same rate as for individuals from white ethnic backgrounds. None of the studies 
explained the reasons for the racial disparity in life expectancy or survival rates. Their 
suggestions included under-ascertainment or under-reporting of congenital heart 
anomalies in white ethnic groups compared to black and minority ethnic groups (Yang 
et al., 2002;  Rasmussen et al., 2006; Shin et al., 2007). Friedman (2001) also 
suggested that differences in factors associated with improved health such as 
community support or access to preventative health care may account for this 
disparity.   
As for people with intellectual disabilities who do not have Down syndrome, 
comorbidities and severe intellectual disabilities were associated with lower life 
expectancy and earlier death, highlighting the importance of health care for infants, 
children and adults with Down syndrome. Antenatal care is also clearly important due 
to the finding on lower birth weight, and younger maternal age; as is support for 
parents thereafter, demonstrated by the association of poorer outcomes for the Down 
syndrome offspring with lower educational achievements of parents.  
This review has identified different cause of mortality patterns in people with Down 
syndrome compared to the general population. Respiratory illness (particularly 
pneumonia) was a significantly more common cause of death for people with Down 
syndrome compared to the general population, due to their anatomical and 
physiological differences. However, aspiration pneumonia is a preventable cause of 
death with the right support and health care, and points to the need for greater 
awareness and training on this for professionals, support staff and families; and 
pneumonia is amenable to health care. People with Down syndrome require prolonged 
periods of treatment in order to overcome respiratory infection (Ram & Chinen, 2011).  
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Individuals with Down syndrome were more likely to die from amenable causes such 
as pneumonia and some congenital cardiac anomalies. Synthesis of these studies 
also revealed that individuals with Down syndrome were less likely to die from causes 
that could be prevented through public health interventions such as certain cancers 
and accidents. These findings echoed findings from that of another systematic review 
that revealed that individuals with intellectual disabilities in general were more likely to 
die from amenable than preventable causes (O’Leary et al., 2017). 
There is an increased recognition of dementia as an issue for the ageing population 
of people with Down syndrome (McCarron et al., 2014). Only two of the studies in this 
review reported dementia as an underlying cause of death, probably reflecting the 
small population sizes of people with Down syndrome at old age included in the 
studies.  
Health gains and areas for improvement   
The findings from this review have demonstrated that the age of death and life 
expectancy of a subset of people with Down syndrome has improved over time. This 
may reflect an improvement in medical intervention and health care particularly for 
individuals with congenital defects. However health care improvements need to be 
further improved and better tailored to the needs of specific subgroups, so that they 
can achieve a longer life expectancy; including people with repeated respiratory 
infections and/or cardiac anomalies. This is important in order to reduce risk of 
avoidable causes of death and increase life expectancy for all individuals with Down 
syndrome.  
Limitations of studies   
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This review aimed to synthesise evidence for mortality patterns of comparable 
samples of individuals with Down syndrome. However, some studies were limited 
through reliance on administrative data, omission of infants and young children with 
Down syndrome, or through identifying people with Down syndrome via entries on 
death certificates which is highly likely to undercount the population. (Others were 
population-based birth cohorts, or identified the people with Down syndrome via 
multiple sources). All studies except one were conducted in high income countries, 
restricting generalisation to within such countries. 
The accuracy of underlying /primary and contributory cause of death results was 
compromised by the reliance on death certificates, which are completed by many 
doctors. Death certificates are subject to coding errors, as physicians are often not 
familiar with the coding rules for completing death certificates (Landes & Peek, 2013). 
This may lead to the risk of incorrect attribution of an easily identifiable condition such 
as Down syndrome as an underlying cause of death (Baird & Sadovnick, 1990). Also, 
the cause of death recording process is often not undertaken consistently by medical 
practitioners working in different regions. Therefore, it may be difficult to obtain a 
consistent picture of the leading and underlying causes of death across different 
countries and regions. 
Also, reliability of findings in two of the cause of death studies may be critiqued by the 
fact that they were limited by 20 or less deaths (McGrother & Marshall, 1990; Brookes 
& Alberman, 1996), and four studies provided very limited or incomplete details in 
relation to causes of death (Bell et al., 1989; Mikkelsen et al., 1990; Hayes 1997; 
Glasson et al., 2016).  As there was a limited number of studies that investigated 
causes of death and limited sample sizes, it was also difficult to determine how cause 
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of death has changed over time. For this reason, it was also difficult to extrapolate 
patterns in cause of death by specific age groups, countries or health care systems.  
There was limited information in relation to the morbidity sequence leading to mortality 
in most of these studies. For example, Goldman et al., (2011) did not distinguish 
between underlying and multiple cause of death in their study and grouped both causal 
categories together. Similarly, Englund et al., (2012) did not distinguish between main 
and contributory causes in their study and only six studies reported intermediate or 
contributory causes of death. Hence it is not possible to build a clear and consistent 
picture of the chain of events leading to mortality for individuals with Down syndrome 
from all of the studies included in the systematic review.  
The analysis of the results was limited in most studies, as they did not adjust for 
potential confounding factors such as gender, so it is difficult to determine whether 
these variables influenced age or cause of death. Comparison groups did not all take 
age into account. 
Strengths and limitations of the review   
The Methodological Quality of Systematic Reviews checklist (AMSTAR, 2015) was 
used to assess the quality of the systematic review. The research protocol and 
objectives were registered with the International Prospective Register of Systematic 
Reviews. This ensured that the aims of the study were rigorously adhered to. This 
protocol informed a comprehensive search strategy comprising specific keywords, and 
papers were selected against pre-defined eligibility criteria. 
The majority of the studies were undertaken in high income countries and were 
restricted to English publications. This limits global generalisability, and capacity to 
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elucidate culture distinctions amongst individuals with Down syndrome related to life 
expectancy, age, and causes of death. This is a notable limitation as it is predicted 
that the improvements in life expectancy and age of death for individuals with 
congenital heart anomalies may not emerge across specific low and middle-income 
countries. This may be because surgical and care interventions for individuals with 
congenital heart anomalies are complex and resource-intensive, and therefore may 
not be accessible to individuals in such regions (Bernier et al., 2010, but the lack of 
representation of low and middle income countries precluded distinctions on the basis 
of different health care systems.   
Although studies that reported post-treatment or post-treatment deaths were not 
included in this review, some included studies may have some participants who had 
cardiac surgery. Therefore this may have influenced survival outcomes for some of 
the participants in these studies.  
 
The findings from this review had to be synthesised using narrative analysis, due to 
the incomparable nature of the studies in the review. This approach carries the risk of 
being more biased than a meta-analysis (Cooper & Rosenthal, 1980). However quality 
appraisal was ensured through checking a proportion of study titles, abstracts and full 
papers with a 2nd reviewer. The critical appraisal (CASP) checklist was also used to 
reduce this bias, as each specific study was given a formal quality assessment score, 
and this was verified with a 2nd and 3rd reviewer: the quality of studies varied, including 
with regards to representativeness.  
This appraisal of the strengths and limitations of the review was conducted by the team 
who completed the review, and so may be subject to unintentional bias. 
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Conclusions  
This review has revealed that people with Down syndrome are now living longer and 
die up to 28 years younger than the general population in high income countries. Age 
of death has notably increased in recent years, particularly for individuals with 
congenital heart anomalies. This may be due to improvements in diagnosing and 
treating these conditions. However, these improvements have not been observed 
across all sub groups of individuals with Down syndrome, and ethnic differences in 
particular warrant further investigation. The pattern of cause of death differed from the 
general population, with congenital heart anomalies and respiratory illness being most 
common, some of which may be amenable to improved healthcare. There is a need 
for improved standardisation and rigorous reporting of the underlying, primary and 
contributory causes of death across countries.  
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